• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Tobacco Products

  • Print
  • Share
  • E-mail
  • en Español en Español

Distributors, Importers, Retailers, and Wholesalers Stakeholder Discussion Series Session

The U.S. Food and Drug Administration (FDA) Center for Tobacco Products (CTP) hosted its sixth Stakeholder Discussion Series session with Distributors, Importers, Retailers, and Wholesalers from 8:45 am to 5:00 pm on Wednesday, August 24, 2011 at the:

Dallas Marriott City Center
650 North Pearl Street
Dallas, TX 75201

The U.S. Food and Drug Administration (FDA) Center for Tobacco Products (CTP) is charged with implementing the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) with the goal of reducing the tremendous toll of disease and death caused by tobacco product use.

In order to better ensure the opportunity for meaningful engagement and dialogue between CTP and public health advocates, a limited number of individuals have been invited to actively participate in the discussion. This approach is based on feedback we have received from stakeholder input on the design of these sessions. Approximately 30 members of the public -- or additional representatives of the groups. A conference line is also provided for additional people to listen via phone. Please see the registration policy for instructions on registering as an in person observer or for additional details about the conference line.


Stakeholder Discussion Series Session Materials

 

 

Meeting Presentations

If you need assistance to access these documents, please email the FDA Center For Tobacco Products.

 

View the Stakeholder Discussion Series Sessions Schedule